Synthesis of water soluble fulleropyrrolidines bearing biologically active arylpiperazines

Tetrahedron

Volumn 59, Issue 34, 2003, Pages 6569-6577

  Illescas, Beatriz M ^a   Martínez Alvarez, Roberto ^a   Fernández Gadea, Javier ^b   Martín, Nazario ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Polígono Industrial   (Spain)

Author keywords

Arylpiperazines; Cycloaddition; Fulleropyrrolidines

Indexed keywords

AZOMETHINE YLIDE; NITROGEN; PIPERAZINE DERIVATIVE; PYRROLIDINE DERIVATIVE; WATER;

ARTICLE; CHEMICAL STRUCTURE; CYCLOADDITION; PRIORITY JOURNAL; SOLUBILITY; SYNTHESIS;

EID: 0043204453     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(03)01017-2     Document Type: Article

References (43)

1. (a) Da Ros T., Prato M. Chem. Commun. 1999;663-669
2. (b) Jensen A.W., Wilson S.R., Schuster D.I. Bioorg. Med. Chem. 4:1996;767-779.
3. (a) Friedman S.H., DeCamp D.L., Sijbesma R.P., Srdanov G., Wudl F., Kenyon G.L. J. Am. Chem. Soc. 115:1993;6506-6508
4. (b) Sijbesma R., Srdanov G., Wudl F., Castoro J.A., Wilkins C., Friedman S.H., DeCamp D.L., Kenyon G.L. J. Am. Chem. Soc. 115:1993;6510-6512
5. (c) Friedman S.H., Ganapathi P.S., Rubin Y., Kenyon G.L. J. Med. Chem. 41:1998;2424-2429.
6. Tokuyama H., Yamago S., Nakamura E., Shiraki T., Sugiura Y. J. Am. Chem. Soc. 115:1993;7918-7919.
7. Boutorine A.S., Tokuyama H., Takasugi M., Isobe H., Nakamura E., Hélène C. Angew. Chem. Int. Ed. Engl. 33:1994;2462.
8. (a) Dugan L.L., Turetsky D.M., Du C., Lobner D., Wheeler M., Almli C.R., Shen C.K.-F., Luh T.-Y., Choi D.W., Lin T.-S. Proc. Natl Acad. Sci. USA. 94:1997;9434
9. (b) Hirsch A., Lamparth I., Karfunkel H.R. Angew. Chem., Int. Ed. Engl. 33:1994;437.
10. (a) Wei X., Migfei W., Qi L., Xu Z. J. Chem. Soc., Perkin Trans. 2. 1997;1389-1393
11. (b) Sawamura M., Nagahama N., Toganoh M., Hackler U.E., Isobe H., Nakamura E., Zhou S.-Q., Chu B. Chem. Lett. 2000;1098-1099.
12. (a) Andersson T., Nilsson K., Sundahl M., Westman G., Wennerstrom O. J. Chem. Soc., Chem. Commun. 1992;604-606
13. (b) Priyadarsini K.I., Mohan H., Tyagi A.K., Mittal J.P. J. Phys. Chem. 98:1994;4756-4759
14. (c) Ikeda A., Hatano T., Kawaguchi M., Suenaga H., Shinkai S. Chem. Commun. 1999;1403-1404
15. (d) Rio Y., Nierengarten J.-F. Tetrahedron Lett. 43:2002;4321-4324.
16. (a) Brettreich M., Hirsch A. Tetrahedron Lett. 39:1998;2731-2734
17. (b) Takenaka S., Yamashita K., Takagi M., Hatta T., Tsuge O. Chem. Lett. 1999;321-322
18. (c) Richardson C.F., Schuster D.I., Wilson S.R. Org. Lett. 2:2000;1011-1014.
19. (a) Da Ros T., Prato M., Novello F., Maggini M., Banfi E. J. Org. Chem. 61:1996;9070-9072
20. (b) Rio Y., Nicoud J.-F., Rehspringer J.-L., Nierengarten J.-F. Tetrahedron Lett. 41:2000;10207
21. (c) Wharton T., Kini V.U., Mortis R.A., Wilson L.J. Tetrahedron Lett. 42:2001;5159-5162.
22. Illescas B.M., Martínez-Grau M.A., Torres M.L., Fernández-Gadea J., Martín N. Tetrahedron Lett. 43:2002;4133-4136.
23. (a) Hibert M.F., Gittos M.W., Middlemiss D.N., Mir A.K., Fozard J.R. J. Med. Chem. 31:1988;1087
24. (b) Misztal S., Bojarski A., Mackowiak M., Boksa J., Bieleeka Z., Mokrosz J.L. Med. Chem. Res. 2:1992;82
25. (c) Chilmonczyk Z., Lcs A., Wozniakowska A., Cybulski J., Koziol A., Gdaniec M. J. Med. Chem. 38:1995;1701.
26. Glennon R.A., Dukat M., Westkaemper R.B. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. CD-Rom Ed. 1999;Raven, New York.
27. Kuipers W., Kruse C.G., van Wijngaarden I., Standaar P.J., Tulp M.T.M., Veldman N., Spek A.L., Ijzerman A.P. J. Med. Chem. 40:1997;300.
28. Gerge P., Borg F., O'Connor S. Eur. J. Med. Chem. 30:1995;299.
29. (a) Barbaro R., Betti L., Botta M., Corelli F., Giannaccini G., Maccari L., Manetti F., Strappaghetti G., Corsano S. J. Med. Chem. 44:2001;2118
30. (b) Betti L., Botta M., Corelli F., Floridi M., Giannaccini G., Maccari L., Manetti F., Strappaghetti G., Tafi A., Corsano A. J. Med. Chem. 45:2002;3603
31. (c) Betti L., Floridi M., Giannaccini G., Manetti F., Strappaghetti G., Tafi A., Botta M. Bioorg. Med. Chem. Lett. 13:2003;171-173.
32. Reviews: (a) Prato M., Maggini M. Acc. Chem. Res. 31:1998;519 (b) Tagmatarchis N., Prato M. Synlet. 2003;768.
33. Reviews: (a) Prato M., Maggini M. Acc. Chem. Res. 31:1998;519 (b) Tagmatarchis N., Prato M. Synlet. 2003;768.
34. (a) Tanaka A., Terasawa T., Hagihara H., Sakuma Y., Ishibe N., Sawada M., Takasugi H., Tanaka H. J. Med. Chem. 41:1998;2390
35. (b) Bader H., Hansen A.R., McCarty F.J. J. Org. Chem. 31:1966;2319.
36. Barrow M.P., Feng X., Wallace J.I., Boltalina O.V., Taylor R., Derrick P.J., Drewello T. Chem. Phys. Lett. 330:2000;267.
37. Rio Y., Accorsi G., Nierengarten H., Rehspringer J.-L., Hönerlage B., Kopitkovas G., Chugreev A., Van Dorsselaer A., Armaroli N., Nirengarten J.-F. New J. Chem. 9:2002;1146.
38. Charbonnier F., Berthelot L., Rolando C. Anal. Chem. 71:1999;1585.
39. Van Berkel G.J. Cole R.B. Electrospray Ionization Mass Spectrometry: Fundamentals, Instrumentation and Applications. 1997;65-105 Wiley, New York. and references cited therein.
40. Rondeau D., Kreher D., Cariou M., Hudhomme P., Gorgues A., Richomme P. Rapid Commun. Mass Spectrom. 15:2001;1708.
41. Rondeau D., Martineau C., Blanchard P., Roncali J. J. Mass Spectrom. 37:2002;1081.
42. Fati D., Leeman V., Vasil'ev Y.V., Drewello T., Leyh B., Hungerbühler H. J. Am. Soc. Mass Spectrom. 13:2002;1448.
43. The measured solubility is in the range of that determined for other related fulleropyrrolidines endowed with oligoether chains. See: Bosi S., Da Ros T., Castellano S., Banfi E., Prato M. Bioorg. Med. Chem. Lett. 10:2000;10431.